Why is Torrent Pharma falling/rising?

As of 20-Aug, Torrent Pharmaceuticals Ltd. is experiencing a price increase, currently at Rs 3,669.70, reflecting a rise of 27.8 points or 0.76%. The stock has shown strong performance, trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. It is also close to its 52-week high, being just 3.28% away from Rs 3,790. Over the past week, the stock has outperformed the sector by 1.18% and has generated a return of 9.36% year-to-date, significantly outperforming the benchmark Sensex, which has only increased by 4.76% in the same period. However, there has been a notable decline in investor participation, with delivery volume falling by 41.71% compared to the 5-day average.
In the broader market context, Torrent Pharmaceuticals has demonstrated consistent returns over the last three years, outperforming the BSE500 in each of the last three annual periods. The company has maintained high management efficiency, evidenced by a return on capital employed (ROCE) of 22.33% and a low debt-to-EBITDA ratio of 1.26 times, which indicates a strong ability to service debt. Additionally, the company has reported positive results for the last eight consecutive quarters, further bolstering investor confidence. With high institutional holdings at 24.75%, the stock is supported by investors who possess the resources to analyze its fundamentals effectively. This combination of strong financial performance and institutional backing contributes to the stock's upward movement despite the recent drop in trading volume.